Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.

ABSTRACT:

Importance

No guidelines at present describe when fludeoxyglucose F 18-labeled positron emission tomography and computed tomography (FDG PET-CT) should be used in the initial posttreatment period for evaluation of oropharyngeal squamous cell carcinoma treatment outcome and recurrence.

Objective

To compare accuracies of the initial posttreatment PET-CT between primary treatment groups and to define indicators of false-positive findings.

Design, setting, and participants

This retrospective cohort study identified adults with a new diagnosis of oropharyngeal squamous cell carcinoma who received treatment with curative intent from October 1, 2006, through November 30, 2016, using the Alberta Cancer Registry (n = 380). Patients who underwent PET-CT within 1 year of treatme

SUBMITTER: Sivarajah S 

PROVIDER: S-EPMC6248186 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature